The BioMed X Institute
A new research team at XSeed Labs - a collaboration between BioMed X and Boehringer Ingelheim, will develop disease models to understand wound healing and fibrosis.
RIDGEFIELD, CT / ACCESSWIRE / June 5, 2024 / XSeed Labs - a collaboration between BioMed X and Boehringer Ingelheim, announces the start of its first research team on the Boehringer Ingelheim campus in Ridgefield, Connecticut. This research team's main objective is to develop complex, physiologically relevant disease models that deepen our understanding of dysfunctional wound healing and fibrosis. The end goal is to study fibrosis, drug delivery strategies, and drug safety in parallel, in an effort to bridge the gap between research and development to improve patient outcomes accurately and efficiently.
The new research team is led by Dr. Lorenzo Talà, Group Leader at XSeed Labs. "Due to insufficient understanding of the mechanisms driving their pathology, therapies to treat fibrotic diseases are limited. The aim of our research group is to develop physiologically relevant in vitro and in silico fibrosis models. By combining both approaches, we will interrogate disease mechanisms, identify drug delivery pathways, and assess drug safety in order to facilitate drug development toward resolving fibrotic tissues."
Christian Tidona, Founder and Managing Director of the BioMed X Institute: "We are pleased that we could successfully translate the innovation model we established in Heidelberg and New Haven to work inside a major pharma research and development campus. We have a long history of successful collaboration with Boehringer Ingelheim at our Heidelberg institute, and we are proud to extend this collaboration to their U.S. headquarters in Ridgefield, Connecticut."
"We are committed to accelerating innovation across fibrotic diseases. This partnership allows us to harness top talent across the biomedical industry and leverage our leading research and development site in the U.S. to discover insights that could help transform the way we treat these diseases," said Carine Boustany, PhD, U.S. Research Site Head and Global Head of Immunology and Respiratory Diseases Research, Boehringer Ingelheim. "In parallel, we will harness these innovative disease model systems to assess the safety of novel anti-fibrotic concepts, and identify better ways to deliver our molecules," said Xiaorong He, PhD, U.S. Development Site Head and Global Head of Development Sciences, Boehringer Ingelheim.
"We are excited to start our first XSeed Labs team at Boehringer Ingelheim in Ridgefield. It is the beginning of a unique innovation model that promotes scientific exchange between major players in biomedical research," says Mark Johnston, CEO of BioMed X USA.
About BioMed X and XSeed Labs
BioMed X is an independent research institute with sites in Heidelberg, Germany, New Haven, Connecticut, XSeed Labs in Ridgefield, Connecticut, and a worldwide network of partner locations. Together with our partners, we identify big biomedical research challenges and provide creative solutions by combining global crowdsourcing with local incubation of the world's brightest early-career research talents. Each of the highly diverse research teams at BioMed X has access to state-of-the-art research infrastructure and is continuously guided by experienced mentors from academia and industry. At BioMed X, we combine the best of two worlds -- academia and industry -- and enable breakthrough innovation by making biomedical research more efficient, more agile, and more fun.
BioMed X started working with Boehringer Ingelheim in 2015 with a series of joint research projects hosted by the BioMed X Institute in Heidelberg, Germany. The new collaboration model - called XSeed Labs - entails an open innovation incubator embedded in the Boehringer Ingelheim Ridgefield campus in Connecticut, USA.
Contact Information
Flavia-Bianca Cristian
Recruiting & Communications Manager
fbc@bio.mx
+49 6221 426 11 706
Swathi Lingam
Scientific Communication & Editorial Associate
lingam@bio.mx
+49 6221 426 11 27
Related Images
SOURCE: BioMed X Institute & XSeed Labs
To view this piece of content from stats.nwe.io, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Compliance Couture: How SMX and CETI are Changing the Rules for Fashion Sustainability (NASDAQ: SMX)15.10.2025 19:10:00 CEST | Press release
NEW YORK, NY, NY / ACCESS Newswire / October 15, 2025 / Global fashion brands require a single, essential ingredient to thrive: trust. Trust that its product is genuine, trust that the craftsmanship is authentic, and trust that the values behind the brand align with the ones it promotes. From Paris ateliers to fast-fashion retailers, every label's reputation depends on that same promise of quality, consistency, and credibility. But the world has changed. Supply chains have gone global. Sustainability has become a shareholder demand. And the old way of proving trust - through reputation alone - no longer cuts it. Today, trust must be earned through evidence. That's where SMX (NASDAQ:SMX) and CETI, the European Center for Innovative Textiles, come in. Together, they've created something fashion has needed for years: proof. Their industrial-scale collaboration embeds molecular-level traceability directly into textile fibers, giving every material its own unbreakable digital fingerprint. I
Matters.AI Announces $6.25 Million Funding to Launch the First AI Security Engineer That Keeps Enterprise Data Security on Autopilot15.10.2025 15:00:00 CEST | Press release
Matter.AI's autonomous system functions like an AI security engineer, understanding context, monitoring behavior, and protecting sensitive data SAN FRANCISCO, CA / ACCESS Newswire / October 15, 2025 / Matters.AI, an AI-native data security company, today announced $6.25 million in funding to pioneer a new class of data protection system, the AI Security Engineer. Funding consists of a $4.75 million Seed Round, co-led by Kalaari Capital and Endiya Partners, with participation from Better Capital, Carya Venture Partners, and leading cybersecurity angels, and an earlier $1.5 million pre-Seed Round led by Better Capital and Carya Venture Partners. The raise will fuel research and development in predictive defense, a US expansion, and scaling engineering to meet enterprise demand.Keshav Murthy, CEO & Co-Founder and Harsh Sahu, CTO & Co-Founder, Matters.AI Matters.AI is designed to function like an AI security engineer, giving enterprises one autonomous system that can see, understand, and p
Camino to Commence Drilling at its Los Chapitos Copper Project in Peru; Peru's Ministry of Energy and Mines Names Los Chapitos Among Top 15 Priority Exploration Projects15.10.2025 12:00:00 CEST | Press release
VANCOUVER, BC, AB / ACCESS Newswire / October 15, 2025 / Camino Minerals Corporation (TSXV:COR)(OTCID:CAMZF) ("Camino" or the "Company") is pleased to announce the mobilization of drilling equipment to commence the discovery drilling campaign at its Los Chapitos copper project in Peru ("Los Chapitos" or the "Project"). The 2025 exploration campaign with Camino's partner, Nittetsu Mining Co., Ltd. ("Nittetsu"), resulted in the identification of several prospective drilling targets. The drilling campaign will focus on two main objectives: discovering new copper-silver deposits in newly identified and undrilled targets, such as Mirador, Piloto, Maqui, and Sombrero Blanco, where notable copper occurrences have been found with high copper and silver values according to geochemical results of rocks in trenches, and extending known mineralization in previously drilled Adriana, Lourdes, and Katty (Enjambre) zones. Highlights: The latest results of trenching at the targets to be drilled showe
GoodData Reports Record Q3 Growth as It Expands AI Leadership15.10.2025 10:00:00 CEST | Press release
SAN FRANCISCO, CA, CA / ACCESS Newswire / October 15, 2025 / GoodData, a leading analytics and data intelligence company, today announced record Q3 results driven by its strongest net new sales ever, the acquisition of Understand Labs, and the launch of its new Full-Stack Intelligence Platform. The quarter underscored the company's accelerating enterprise adoption, growing international footprint, and continued investment in AI innovation. Business highlights GoodData's momentum continued to build in Q3, delivering its best-ever net new annual recurring revenue (ARR) performance. Enterprise engagement was a key driver of this success, with 90% of enterprise opportunities now progressing toward AI and agentic deployments. GoodData's acquisition of Understand Labs, a leader in semantic AI and natural language processing, further strengthened its AI-native capabilities. The addition of Understand Labs' technology will enhance the intelligence of GoodData's platform, enabling more natural,
Graid Technology Announces Strategic License Agreement With Intel Corporation to Accelerate RAID Innovation14.10.2025 18:00:00 CEST | Press release
SANTA CLARA, CALIFORNIA / ACCESS Newswire / October 14, 2025 / Graid Technology announced an agreement with Intel Corporation to enter into a license agreement granting Graid Technology the rights to develop, market, sell, and support Intel® Virtual RAID on CPU (Intel® VROC) globally. This strategic agreement is expected to accelerate innovation in the enterprise RAID market and deliver transformative outcomes for data center customers worldwide.Graid Technology and Intel Announce Strategic License Agreement In today's digital economy, data is the most valuable asset for every organization, and ensuring it is both resilient and readily available is critical to unlocking its full value. Through this agreement, Graid Technology will combine the proven enterprise performance of Intel® VROC with the breakthrough innovation of its own SupremeRAID™ portfolio, the industry's first GPU-based RAID architecture for high-performance workloads such as AI and HPC. By bringing together CPU-based and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom